BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome

Brain Struct Funct. 2020 Jul;225(6):1743-1760. doi: 10.1007/s00429-020-02090-x. Epub 2020 May 28.

Abstract

Restless legs syndrome (RLS) is characterized by an urge to move legs, usually accompanied by uncomfortable sensations. RLS symptoms generally happen at night and can be relieved by movements. Genetic studies have linked polymorphisms in BTBD9 to a higher risk of RLS. Knockout of BTBD9 homolog in mice (Btbd9) and fly results in RLS-like phenotypes. A dysfunctional dopaminergic system is associated with RLS. However, the function of BTBD9 in the dopaminergic system and RLS is not clear. Here, we made use of the simple Caenorhabditis elegans nervous system. Loss of hpo-9, the worm homolog of BTBD9, resulted in hyperactive egg-laying behavior. Analysis of genetic interactions between hpo-9 and genes for dopamine receptors (dop-1, dop-3) indicated that hpo-9 and dop-1 worked similarly. Reporter assays of dop-1 and dop-3 revealed that hpo-9 knockout led to a significant increase of DOP-3 expression. This appears to be evolutionarily conserved in mice with an increased D2 receptor (D2R) mRNA in the striatum of the Btbd9 knockout mice. Furthermore, the striatal D2R protein was significantly decreased and Dynamin I was increased. Overall, activities of DA neurons in the substantia nigra were not altered, but the peripheral D1R pathway was potentiated in the Btbd9 knockout mice. Finally, we generated and characterized the dopamine neuron-specific Btbd9 knockout mice and detected an active-phase sleepiness, suggesting that dopamine neuron-specific loss of Btbd9 is sufficient to disturb the sleep. Our results suggest that increased activities in the D1R pathway, decreased activities in the D2R pathway, or both may contribute to RLS.

Keywords: Btbd9; Dopamine receptors; Dynamin-1; Restless legs syndrome; hpo-9.

MeSH terms

  • Animals
  • BTB-POZ Domain / physiology*
  • Caenorhabditis elegans
  • Caenorhabditis elegans Proteins / physiology*
  • Disease Models, Animal
  • Dopamine / administration & dosage
  • Dopamine / physiology*
  • Dopaminergic Neurons / physiology
  • Dynamin I / metabolism
  • Female
  • Male
  • Mice, Knockout
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology*
  • Receptors, Dopamine D2 / metabolism
  • Restless Legs Syndrome / physiopathology*
  • Substantia Nigra / physiology

Substances

  • Btbd9 protein, mouse
  • Caenorhabditis elegans Proteins
  • DRD2 protein, mouse
  • Nerve Tissue Proteins
  • Receptors, Dopamine D2
  • Dynamin I
  • Dopamine